SlideShare a Scribd company logo
1 of 10
LET’S GET PAID!!!
REIMBURSEMENT FOR CHEMOTHERAPY DRUGS
TOP 10 CONCERNS FROM OFFICE
STAFF REGARDING NEW DRUGS
• NEW DRUGS ARE BEING PRESENTED TO THE PHYSICANS BY DRUG COMPANIES MORE
AGGRESSIVELY
• PHYSICANS WANT TO USE THE DRUG YESTERDAY
• “HOW DO WE BILL FOR A NEW DRUG?”
• “WHAT CODE DO I USE?”
• “WE HAVE THE DRUG NOW WHAT?”
• “WE WILL NOT GET PAID!”
• “ WHY DID WE RECEIVE A DENIAL?”
• “TOO MUCH HASSLE TO GET THIS CLAIM PAID FOR!”
• “OH WELL, WE WILL WRITE THIS CHARGE OFF, WE ARE A BIG PRACTICE”
• I’LL NEED MORE STAFF TO WORK THE DENIALS
PREPARING FOR NEW DRUG
UTILIZATION
• MEET OR CALL DRUG REPRESENTATIVES AND ASK FOR INFORMATION
REGARDING NEW DRUG:
• REQUEST INFORMATION ON THE FOLLOWING:
• MISC CODE
• REIMBURSEMENT ASSISTANCE
• PROVIDER SITE OR PORTAL
• BENEFIT INVESTIGATION
• MEDICARE/MEDICAID APPROVED?
• DENIALS AND APPEALS ASSISTANCE
• DRUG PROVIDED UPFRONT WHILE REIMBURSEMENT PROCESS IS BEING DONE?
DRUG EDUCATION PROCESS
• ACCESS DRUG COMPANY’S WEBSITE FOR THE SPECIFIC DRUG YOU ARE USING:
• EXAMPLE DRUG: OPDIVO
DRUG COMPANY: BRISTOL MYERS SQUIBB
UTILIZE BENEFIT INVESTIGATION FORMS…..OBTAIN BILLING CODE INFORMATION…PATIENT
ASSISTANCE
DRUG COVERAGE AND BENEFITS
• CHECK NCCN GUIDELINES/MEDICARE/FDA APPROVAL BY DIAGNOSIS
• MEDICARE GUIDELINES (NOVITAS DRUG CODE LOOK UP)
• DRUG POLICY BY CARRIER (EXAMPLE: AETNA POLICY)
• COMPLETE BENEFIT INVESTIGATIONS ON ALL INSURANCE CARRIERS
• (BMS ENROLLMENT FORM)
• PRE-DETERMINATIONS AND AUTHORIZATIONS COMPLETED
• BENEFIT INVESTIGATION RETURNED:
APPROVED
DETAIL GUIDELINES GIVEN FOR REIMBURSEMENT OR DENIAL
APPEALS SUPPORT
CLAIM BILLING
FOLLOW DRUG COMPANY GUIDELINES FOR BILLING:
USE J CODES
INCLUDE CPT CODE 96413
NDC CODES FOR EACH UNCLASSIFIED DRUG
ALL CODES NEED TO BE ON HCFA CLAIM FORM
•If the miscellaneous service is a
drug (e.g., J3490), the NDC
number of the drug and dosage
information should be listed on the
claim.
TRAINING
• TRAIN STAFF USING PROTOCOL ANALYZER FROM ION SOLUTION
Remove the estimation or guess of drug costs
Find Chemotherapy Treatment plans or pathways
Fee Schedules are attached to analyzer
Analyzer shows cost of drug and reimbursement status for practice
Estimated cost for patient
Printed form for patient to sign for financial responsibility
HANDOUTS: PROTOCOL ANAYLZER DRUG COST AND PATIENT FORM
PATIENT ASSISTANCE PROGRAMS
• ENROLL ALL PATIENTS IN COPAY/COINSURANCE PROGRAMS FOR
OOP/DEDUCTIBLES
PRACTICE DOESN’T HAVE TO BILL PATIENT FOR LARGE PERCENTAGES OF
COINSURANCES!
And Yes even if: DED/OOP MET
Enrolling once protects the practice against:
• LOSS OF INSURANCE
• NEW INSURANCE
• NEW YEAR BENEFITS
• NEW EMPLOYEES Eliminate Loss of Revenue
APPEALS PROCESS
• REQUEST APPEAL SUPPORT THRU DRUG COMPANY
• HAVE ARTICLES OR DOCUMENTS TO HELP SUPPORT USE OF DRUG.
• PREPARE LETTERS OF MEDICAL NECESSITY
• WORK SMARTER UPFRONT BEFORE CLAIM IS SENT!!!
• OBTAIN BETTER REIMBURSEMENTS WHEN ALL PROCESSES ARE COMPLETED!!
• YOUR STAFF WILL BE SUPER HEROES!!
HANDOUTS: MEDICARE APPEALS
FLOW CHART AND LETTER
HELPFUL TOOLS
• CHECK OFF LIST FOR ALL PROCESSES FOR DRUG APPROVAL AND
REIMBURSEMENT
• DRUG COMPANY PROVIDER PORTALS AND/OR ASSIST POINT
DISCUSS HANDOUTS AND OPEN DISCUSSION
I’M HERE TO HELP WITH ANY QUESTIONS OR CONCERNS!
THANK YOU!

More Related Content

Viewers also liked

CMS Announces Change to Payment Structure for Medicare Part B Drugs By Floyd ...
CMS Announces Change to Payment Structure for Medicare Part B Drugs By Floyd ...CMS Announces Change to Payment Structure for Medicare Part B Drugs By Floyd ...
CMS Announces Change to Payment Structure for Medicare Part B Drugs By Floyd ...Floyd Arthur
 
The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...
The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...
The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...Epstein Becker Green
 
Ocular Therapeutix
Ocular TherapeutixOcular Therapeutix
Ocular TherapeutixHealthegy
 
Pharmaceutical pricing and reimbursement usa
Pharmaceutical pricing and reimbursement usaPharmaceutical pricing and reimbursement usa
Pharmaceutical pricing and reimbursement usaNeha Kalal
 
Developing Your Investment Club's Investment Policy Statement
Developing Your Investment Club's Investment Policy StatementDeveloping Your Investment Club's Investment Policy Statement
Developing Your Investment Club's Investment Policy StatementDoug Gerlach
 
Who Runs the Internet?
Who Runs the Internet?Who Runs the Internet?
Who Runs the Internet?ICANN
 
Strategic management - An Outlook on Growth strategy
Strategic management - An Outlook on Growth strategyStrategic management - An Outlook on Growth strategy
Strategic management - An Outlook on Growth strategyNeha Kalal
 
IFS Construction & Contracting Solution Map
IFS Construction & Contracting Solution MapIFS Construction & Contracting Solution Map
IFS Construction & Contracting Solution MapIFS
 

Viewers also liked (9)

CMS Announces Change to Payment Structure for Medicare Part B Drugs By Floyd ...
CMS Announces Change to Payment Structure for Medicare Part B Drugs By Floyd ...CMS Announces Change to Payment Structure for Medicare Part B Drugs By Floyd ...
CMS Announces Change to Payment Structure for Medicare Part B Drugs By Floyd ...
 
The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...
The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...
The Impact of the AMP Final Rule: Legal, Operational, and Financial Considera...
 
Ocular Therapeutix
Ocular TherapeutixOcular Therapeutix
Ocular Therapeutix
 
Pharmaceutical pricing and reimbursement usa
Pharmaceutical pricing and reimbursement usaPharmaceutical pricing and reimbursement usa
Pharmaceutical pricing and reimbursement usa
 
Developing Your Investment Club's Investment Policy Statement
Developing Your Investment Club's Investment Policy StatementDeveloping Your Investment Club's Investment Policy Statement
Developing Your Investment Club's Investment Policy Statement
 
Who Runs the Internet?
Who Runs the Internet?Who Runs the Internet?
Who Runs the Internet?
 
Strategic management - An Outlook on Growth strategy
Strategic management - An Outlook on Growth strategyStrategic management - An Outlook on Growth strategy
Strategic management - An Outlook on Growth strategy
 
IFS Construction & Contracting Solution Map
IFS Construction & Contracting Solution MapIFS Construction & Contracting Solution Map
IFS Construction & Contracting Solution Map
 
Caligramas
CaligramasCaligramas
Caligramas
 

Similar to LET’S GET PAID!!!

Medical insurance for obstructive sleep apnea
Medical insurance for obstructive sleep apneaMedical insurance for obstructive sleep apnea
Medical insurance for obstructive sleep apneaellencrean
 
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting Services
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting ServicesSupervisor Drug Awareness and Reasonable Suspicion by P&A Consulting Services
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting ServicesAtlantic Training, LLC.
 
Physician dispensing services doctor dispensing brp pharmaceuticals
Physician dispensing services  doctor dispensing   brp pharmaceuticalsPhysician dispensing services  doctor dispensing   brp pharmaceuticals
Physician dispensing services doctor dispensing brp pharmaceuticalsPhysician Dispensing
 
Business Impact Presentation
Business Impact PresentationBusiness Impact Presentation
Business Impact PresentationRobert Coutinho
 
Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?RIAPA
 
outpatient satisfaction survey
outpatient satisfaction surveyoutpatient satisfaction survey
outpatient satisfaction surveyAAYUSHI SAHA
 
TGA Presentation: Medicines scheduling and scheduling policy ad hoc working g...
TGA Presentation: Medicines scheduling and scheduling policy ad hoc working g...TGA Presentation: Medicines scheduling and scheduling policy ad hoc working g...
TGA Presentation: Medicines scheduling and scheduling policy ad hoc working g...TGA Australia
 
Uniform Code for Pharmaceutical Marketing Practices (UCPMP.pptx
Uniform Code for Pharmaceutical Marketing Practices (UCPMP.pptxUniform Code for Pharmaceutical Marketing Practices (UCPMP.pptx
Uniform Code for Pharmaceutical Marketing Practices (UCPMP.pptxNynMotghare1
 
The Future of Connected Medicines - Promise and Pitfalls
The Future of Connected Medicines - Promise and PitfallsThe Future of Connected Medicines - Promise and Pitfalls
The Future of Connected Medicines - Promise and PitfallsChris Hogg
 
Top Five Reasons Physical Therapy Practices Fail
Top Five Reasons Physical Therapy Practices FailTop Five Reasons Physical Therapy Practices Fail
Top Five Reasons Physical Therapy Practices FailJim Cucinotta
 
Rx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinnerRx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinnerOPUNITE
 
Rx15 tpp wed_300_1_paduda-white_2hanna
Rx15 tpp wed_300_1_paduda-white_2hannaRx15 tpp wed_300_1_paduda-white_2hanna
Rx15 tpp wed_300_1_paduda-white_2hannaOPUNITE
 
Price Transparency and No Surprises Act: Details You Need to Know to be Prepared
Price Transparency and No Surprises Act: Details You Need to Know to be PreparedPrice Transparency and No Surprises Act: Details You Need to Know to be Prepared
Price Transparency and No Surprises Act: Details You Need to Know to be PreparedHealthcare Resource Group Inc.
 
Patient Satisfaction
Patient SatisfactionPatient Satisfaction
Patient SatisfactionDirkRhodes
 
Ancillary Revenue Solutions for Clinics Paradigm Shift
Ancillary Revenue Solutions for Clinics Paradigm ShiftAncillary Revenue Solutions for Clinics Paradigm Shift
Ancillary Revenue Solutions for Clinics Paradigm ShiftArney Benson
 
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginleyRx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginleyOPUNITE
 
Price Transparency
Price TransparencyPrice Transparency
Price TransparencyJohn Yeager
 
Cmp new information session ppt
Cmp new information session pptCmp new information session ppt
Cmp new information session pptmjohnston78
 

Similar to LET’S GET PAID!!! (20)

Medical insurance for obstructive sleep apnea
Medical insurance for obstructive sleep apneaMedical insurance for obstructive sleep apnea
Medical insurance for obstructive sleep apnea
 
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting Services
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting ServicesSupervisor Drug Awareness and Reasonable Suspicion by P&A Consulting Services
Supervisor Drug Awareness and Reasonable Suspicion by P&A Consulting Services
 
Physician dispensing services doctor dispensing brp pharmaceuticals
Physician dispensing services  doctor dispensing   brp pharmaceuticalsPhysician dispensing services  doctor dispensing   brp pharmaceuticals
Physician dispensing services doctor dispensing brp pharmaceuticals
 
Business Impact Presentation
Business Impact PresentationBusiness Impact Presentation
Business Impact Presentation
 
Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?
 
outpatient satisfaction survey
outpatient satisfaction surveyoutpatient satisfaction survey
outpatient satisfaction survey
 
Optimize apr13pres
Optimize apr13presOptimize apr13pres
Optimize apr13pres
 
TGA Presentation: Medicines scheduling and scheduling policy ad hoc working g...
TGA Presentation: Medicines scheduling and scheduling policy ad hoc working g...TGA Presentation: Medicines scheduling and scheduling policy ad hoc working g...
TGA Presentation: Medicines scheduling and scheduling policy ad hoc working g...
 
Jamila Fraud & Abuse
Jamila Fraud & AbuseJamila Fraud & Abuse
Jamila Fraud & Abuse
 
Uniform Code for Pharmaceutical Marketing Practices (UCPMP.pptx
Uniform Code for Pharmaceutical Marketing Practices (UCPMP.pptxUniform Code for Pharmaceutical Marketing Practices (UCPMP.pptx
Uniform Code for Pharmaceutical Marketing Practices (UCPMP.pptx
 
The Future of Connected Medicines - Promise and Pitfalls
The Future of Connected Medicines - Promise and PitfallsThe Future of Connected Medicines - Promise and Pitfalls
The Future of Connected Medicines - Promise and Pitfalls
 
Top Five Reasons Physical Therapy Practices Fail
Top Five Reasons Physical Therapy Practices FailTop Five Reasons Physical Therapy Practices Fail
Top Five Reasons Physical Therapy Practices Fail
 
Rx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinnerRx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinner
 
Rx15 tpp wed_300_1_paduda-white_2hanna
Rx15 tpp wed_300_1_paduda-white_2hannaRx15 tpp wed_300_1_paduda-white_2hanna
Rx15 tpp wed_300_1_paduda-white_2hanna
 
Price Transparency and No Surprises Act: Details You Need to Know to be Prepared
Price Transparency and No Surprises Act: Details You Need to Know to be PreparedPrice Transparency and No Surprises Act: Details You Need to Know to be Prepared
Price Transparency and No Surprises Act: Details You Need to Know to be Prepared
 
Patient Satisfaction
Patient SatisfactionPatient Satisfaction
Patient Satisfaction
 
Ancillary Revenue Solutions for Clinics Paradigm Shift
Ancillary Revenue Solutions for Clinics Paradigm ShiftAncillary Revenue Solutions for Clinics Paradigm Shift
Ancillary Revenue Solutions for Clinics Paradigm Shift
 
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginleyRx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
Rx16 pharma wed_1115_1_ryle_2menkhaus_3mcginley
 
Price Transparency
Price TransparencyPrice Transparency
Price Transparency
 
Cmp new information session ppt
Cmp new information session pptCmp new information session ppt
Cmp new information session ppt
 

LET’S GET PAID!!!

  • 1. LET’S GET PAID!!! REIMBURSEMENT FOR CHEMOTHERAPY DRUGS
  • 2. TOP 10 CONCERNS FROM OFFICE STAFF REGARDING NEW DRUGS • NEW DRUGS ARE BEING PRESENTED TO THE PHYSICANS BY DRUG COMPANIES MORE AGGRESSIVELY • PHYSICANS WANT TO USE THE DRUG YESTERDAY • “HOW DO WE BILL FOR A NEW DRUG?” • “WHAT CODE DO I USE?” • “WE HAVE THE DRUG NOW WHAT?” • “WE WILL NOT GET PAID!” • “ WHY DID WE RECEIVE A DENIAL?” • “TOO MUCH HASSLE TO GET THIS CLAIM PAID FOR!” • “OH WELL, WE WILL WRITE THIS CHARGE OFF, WE ARE A BIG PRACTICE” • I’LL NEED MORE STAFF TO WORK THE DENIALS
  • 3. PREPARING FOR NEW DRUG UTILIZATION • MEET OR CALL DRUG REPRESENTATIVES AND ASK FOR INFORMATION REGARDING NEW DRUG: • REQUEST INFORMATION ON THE FOLLOWING: • MISC CODE • REIMBURSEMENT ASSISTANCE • PROVIDER SITE OR PORTAL • BENEFIT INVESTIGATION • MEDICARE/MEDICAID APPROVED? • DENIALS AND APPEALS ASSISTANCE • DRUG PROVIDED UPFRONT WHILE REIMBURSEMENT PROCESS IS BEING DONE?
  • 4. DRUG EDUCATION PROCESS • ACCESS DRUG COMPANY’S WEBSITE FOR THE SPECIFIC DRUG YOU ARE USING: • EXAMPLE DRUG: OPDIVO DRUG COMPANY: BRISTOL MYERS SQUIBB UTILIZE BENEFIT INVESTIGATION FORMS…..OBTAIN BILLING CODE INFORMATION…PATIENT ASSISTANCE
  • 5. DRUG COVERAGE AND BENEFITS • CHECK NCCN GUIDELINES/MEDICARE/FDA APPROVAL BY DIAGNOSIS • MEDICARE GUIDELINES (NOVITAS DRUG CODE LOOK UP) • DRUG POLICY BY CARRIER (EXAMPLE: AETNA POLICY) • COMPLETE BENEFIT INVESTIGATIONS ON ALL INSURANCE CARRIERS • (BMS ENROLLMENT FORM) • PRE-DETERMINATIONS AND AUTHORIZATIONS COMPLETED • BENEFIT INVESTIGATION RETURNED: APPROVED DETAIL GUIDELINES GIVEN FOR REIMBURSEMENT OR DENIAL APPEALS SUPPORT
  • 6. CLAIM BILLING FOLLOW DRUG COMPANY GUIDELINES FOR BILLING: USE J CODES INCLUDE CPT CODE 96413 NDC CODES FOR EACH UNCLASSIFIED DRUG ALL CODES NEED TO BE ON HCFA CLAIM FORM •If the miscellaneous service is a drug (e.g., J3490), the NDC number of the drug and dosage information should be listed on the claim.
  • 7. TRAINING • TRAIN STAFF USING PROTOCOL ANALYZER FROM ION SOLUTION Remove the estimation or guess of drug costs Find Chemotherapy Treatment plans or pathways Fee Schedules are attached to analyzer Analyzer shows cost of drug and reimbursement status for practice Estimated cost for patient Printed form for patient to sign for financial responsibility HANDOUTS: PROTOCOL ANAYLZER DRUG COST AND PATIENT FORM
  • 8. PATIENT ASSISTANCE PROGRAMS • ENROLL ALL PATIENTS IN COPAY/COINSURANCE PROGRAMS FOR OOP/DEDUCTIBLES PRACTICE DOESN’T HAVE TO BILL PATIENT FOR LARGE PERCENTAGES OF COINSURANCES! And Yes even if: DED/OOP MET Enrolling once protects the practice against: • LOSS OF INSURANCE • NEW INSURANCE • NEW YEAR BENEFITS • NEW EMPLOYEES Eliminate Loss of Revenue
  • 9. APPEALS PROCESS • REQUEST APPEAL SUPPORT THRU DRUG COMPANY • HAVE ARTICLES OR DOCUMENTS TO HELP SUPPORT USE OF DRUG. • PREPARE LETTERS OF MEDICAL NECESSITY • WORK SMARTER UPFRONT BEFORE CLAIM IS SENT!!! • OBTAIN BETTER REIMBURSEMENTS WHEN ALL PROCESSES ARE COMPLETED!! • YOUR STAFF WILL BE SUPER HEROES!! HANDOUTS: MEDICARE APPEALS FLOW CHART AND LETTER
  • 10. HELPFUL TOOLS • CHECK OFF LIST FOR ALL PROCESSES FOR DRUG APPROVAL AND REIMBURSEMENT • DRUG COMPANY PROVIDER PORTALS AND/OR ASSIST POINT DISCUSS HANDOUTS AND OPEN DISCUSSION I’M HERE TO HELP WITH ANY QUESTIONS OR CONCERNS! THANK YOU!